- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/52 - Sulfur atoms
Patent holdings for IPC class C07D 213/52
Total number of patents in this class: 33
10-year publication summary
|
4
|
2
|
6
|
3
|
2
|
4
|
0
|
0
|
0
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2167 |
5 |
| PIMCO 2664 Limited | 20 |
5 |
| Enanta Pharmaceuticals, Inc. | 425 |
4 |
| Inflazome Limited | 84 |
3 |
| Atnx Spv, LLC | 34 |
3 |
| University of Southern California | 2132 |
2 |
| Novartis AG | 10262 |
1 |
| Bayer Cropscience AG | 1844 |
1 |
| Amgen Inc. | 4427 |
1 |
| Firmenich SA | 1760 |
1 |
| Kinex Pharmaceuticals, LLC | 9 |
1 |
| TONIX Pharmaceuticals Holding Corp | 32 |
1 |
| University of Arizona | 14 |
1 |
| Washington University | 1737 |
1 |
| Hangzhou Innogate Pharma Co., Ltd. | 66 |
1 |
| Capacity Bio, Inc. | 5 |
1 |
| Cureverse Incorporated | 3 |
1 |
| Other owners | 0 |